JPRN-UMIN000013544已完成未知
A Double-blind Placebo Controlled Study of Acotiamide Hydrochloride for Efficacy on Gastrointestinal Motility of Patients with Functional Dyspepsia - Efficacy of Acotiamide Hydrochloride on Gastrointestinal Motility of Patients with Functional Dyspepsia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with conditions that are likely to cause upper abdominal symptoms such as malignant tumors, peptic ulcers and systemic diseases (neurological diseases including Parkinson's disease, metabolic diseases including diabetes, etc). 2. Patients with known causes of upper abdominal symptoms including excessive drinking, overeating, taking NSAIDs, and sever stress. 3. Patients with predominant GERD 4. Patients with predominant irritable bowel syndrome (IBS) 5. Patients with a history of surgery of the upper gastrointestinal tract including the stomach and esophagus.
研究者
相似试验
已完成
不适用
Single Blind, Placebo-Controlled Study of Acetaminophen for Liver function in Healthy Japanese AdultsDrug-induced liver injury (DILI)JPRN-UMIN000019607Kitasato Clinical Trial Center240
进行中（未招募）
1 期
Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid DyslexiaAttention-Deficit/Hyperactivity DisorderMedDRA version: 23.0Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorderSystem Organ Class: 100000004873EUCTR2017-000739-15-Outside-EU/EEAEli Lilly and Company
尚未招募
2 期
Hand Fracture management in AyurvedaCTRI/2017/12/010769All India Institute of Ayurveda
尚未招募
不适用
A double-blind, placebo-controlled study with A-2 on symptoms of vaginal atrophy in postmenopausal womeHealthy postmenopausal womenJPRN-UMIN000031295Department of Obstetrics and Gynecology, Tokyo Dental College Ichikawa General Hospital50
进行中（未招募）
1 期
A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depressive desorder (MDD).EUCTR2014-004393-41-BECUB Hospital Erasme